The Efficacy of Stem Cells in Wound Healing: A Systematic Review
- PMID: 38474251
- PMCID: PMC10931571
- DOI: 10.3390/ijms25053006
The Efficacy of Stem Cells in Wound Healing: A Systematic Review
Abstract
Wound healing is an intricate process involving coordinated interactions among inflammatory cells, skin fibroblasts, keratinocytes, and endothelial cells. Successful tissue repair hinges on controlled inflammation, angiogenesis, and remodeling facilitated by the exchange of cytokines and growth factors. Comorbid conditions can disrupt this process, leading to significant morbidity and mortality. Stem cell therapy has emerged as a promising strategy for enhancing wound healing, utilizing cells from diverse sources such as endothelial progenitor cells, bone marrow, adipose tissue, dermal, and inducible pluripotent stem cells. In this systematic review, we comprehensively investigated stem cell therapies in chronic wounds, summarizing the clinical, translational, and primary literature. A systematic search across PubMed, Embase, Web of Science, Google Scholar, and Cochrane Library yielded 22,454 articles, reduced to 44 studies after rigorous screening. Notably, adipose tissue-derived mesenchymal stem cells (AD-MSCs) emerged as an optimal choice due to their abundant supply, easy isolation, ex vivo proliferative capacities, and pro-angiogenic factor secretion. AD-MSCs have shown efficacy in various conditions, including peripheral arterial disease, diabetic wounds, hypertensive ulcers, bullous diabeticorum, venous ulcers, and post-Mohs micrographic surgery wounds. Delivery methods varied, encompassing topical application, scaffold incorporation, combination with plasma-rich proteins, and atelocollagen administration. Integration with local wound care practices resulted in reduced pain, shorter healing times, and improved cosmesis. Stem cell transplantation represents a potential therapeutic avenue, as transplanted stem cells not only differentiate into diverse skin cell types but also release essential cytokines and growth factors, fostering increased angiogenesis. This approach holds promise for intractable wounds, particularly chronic lower-leg wounds, and as a post-Mohs micrographic surgery intervention for healing defects through secondary intention. The potential reduction in healthcare costs and enhancement of patient quality of life further underscore the attractiveness of stem cell applications in wound care. This systematic review explores the clinical utilization of stem cells and stem cell products, providing valuable insights into their role as ancillary methods in treating chronic wounds.
Keywords: chronic wound; dermatology; stem cells; wound healing.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Human platelet lysate-cultured adipose-derived stem cell sheets promote angiogenesis and accelerate wound healing via CCL5 modulation.Stem Cell Res Ther. 2024 Jun 9;15(1):163. doi: 10.1186/s13287-024-03762-9. Stem Cell Res Ther. 2024. PMID: 38853252 Free PMC article.
-
Antibiotics and antiseptics for surgical wounds healing by secondary intention.Cochrane Database Syst Rev. 2016 Mar 29;3(3):CD011712. doi: 10.1002/14651858.CD011712.pub2. Cochrane Database Syst Rev. 2016. PMID: 27021482 Free PMC article.
-
Oral aspirin for treating venous leg ulcers.Cochrane Database Syst Rev. 2016 Feb 18;2(2):CD009432. doi: 10.1002/14651858.CD009432.pub2. Cochrane Database Syst Rev. 2016. PMID: 26889740 Free PMC article.
-
Dressings and topical agents for treating venous leg ulcers.Cochrane Database Syst Rev. 2018 Jun 15;6(6):CD012583. doi: 10.1002/14651858.CD012583.pub2. Cochrane Database Syst Rev. 2018. PMID: 29906322 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention.Health Technol Assess. 2001;5(14):1-131. doi: 10.3310/hta5140. Health Technol Assess. 2001. PMID: 11399237
Cited by
-
A Comparative Review of Meshed Versus Unmeshed Grafts in Split-Thickness Skin Grafting: Clinical Implications and Outcomes.Cureus. 2024 Sep 17;16(9):e69606. doi: 10.7759/cureus.69606. eCollection 2024 Sep. Cureus. 2024. PMID: 39429304 Free PMC article. Review.
-
Repeat-dose toxicity of human umbilical cord mesenchymal stem cells via subcutaneous injection in NOG mice.Front Cell Dev Biol. 2025 Mar 3;13:1558310. doi: 10.3389/fcell.2025.1558310. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40099193 Free PMC article.
-
Recent Advances in the Local Drug Delivery Systems for Diabetic Wound Healing: A Comprehensive Review.AAPS PharmSciTech. 2025 Jul 1;26(6):177. doi: 10.1208/s12249-025-03172-x. AAPS PharmSciTech. 2025. PMID: 40593363 Review.
-
Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation.Front Bioeng Biotechnol. 2025 Feb 12;13:1527854. doi: 10.3389/fbioe.2025.1527854. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40013305 Free PMC article. Review.
-
Nanomanaging Chronic Wounds with Targeted Exosome Therapeutics.Pharmaceutics. 2025 Mar 13;17(3):366. doi: 10.3390/pharmaceutics17030366. Pharmaceutics. 2025. PMID: 40143030 Free PMC article. Review.
References
-
- Nakagami H., Maeda K., Morishita R., Iguchi S., Nishikawa T., Takami Y., Kikuchi Y., Saito Y., Tamai K., Ogihara T., et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arter. Thromb. Vasc. Biol. 2005;25:2542–2547. doi: 10.1161/01.ATV.0000190701.92007.6d. - DOI - PubMed
-
- Huldani H., Kozlitina I.A., Alshahrani M., Daabo H.M.A., Almalki S.G., Oudaha K.H., Alawadi A.H., Alsalamy A., Joshi S.K., Mustafa Y.F. Exosomes derived from adipose stem cells in combination with hyaluronic acid promote diabetic wound healing. Tissue Cell. 2023;85:102252. doi: 10.1016/j.tice.2023.102252. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources